"Designing Growth Strategies is in our DNA"

U.S. C-Reactive Protein Testing Market Size, Share & COVID-19 Impact Analysis, By Product (Reagent & Kits and Instruments), By Assay Type (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunoturbidimetric Assay, and Others), By Detection Range (Conventional CRP and Hs-CRP), By Setting (Laboratory Testing, and Point-of-Care (POC) Testing), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: June 03, 2024 | Format: PDF | Report ID: FBI108429

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. c-reactive protein testing market size was worth USD 691.6 million in 2022 and is projected to grow at a CAGR of 5.1% during the forecast period.


C-reactive protein is an acute phase protein produced by the liver as a response to inflammation in the body. This protein serves as a non-specific marker of inflammation. Additionally, the protein level in the blood helps diagnose several life-threatening diseases, such as cardiovascular diseases, cancer, rheumatoid arthritis, and others.



  • For instance, according to an article published by NCBI in December 2020, in rheumatoid arthritis (RA), the levels of c-reactive protein are routinely assessed. These results are also important in inflammatory pathways associated with RA.


C-reactive protein testing is important in reducing the antibiotic prescriptions given to healthcare professionals to treat any disease. Several studies have been conducted to evaluate the use of this protein testing in primary care settings to reduce antibiotic prescriptions. These tests are increasingly being supported to improve antibiotic control and reduce diagnostic uncertainty.


The COVID-19 pandemic resulted in a positive impact on the market with an increased testing among U.S. patients. The U.S. witnessed exponential market growth in 2020 due to the increased use of these tests to understand the severity of the COVID-19 infection based on levels of this protein.


LATEST TRENDS


Emphasis on the Development of Technologically Advanced Products 


In recent years, the market is witnessing an increasing trend of development and launch of point-of-care testing products for c-reactive protein. The operating players focus on introducing POC tests to capture the untapped market avenues. Furthermore, the development of high sensitivity c-reactive protein assays also served as a growing trend in the market.



  • For instance, Orion Diagnostica Oy has launched QuickRead CRP test, which can be used on QuikRead go point of care instrument. This test provides results in two minutes.


DRIVING FACTORS


Rising Prevalence of Chronic Diseases to Drive Demand for C-Reactive Protein Testing


The country’s prevalence of chronic diseases, including cancer, cardiovascular diseases, and autoimmune diseases such as inflammatory bowel disease, is increasing. This test is commonly used in determining the severity of these disease conditions. High levels of this protein in the body indicate chronic inflammation.


A rise in demand for this test to diagnose and manage various chronic diseases is expected to drive market expansion in the coming years.



  • According to an article published in NCBI in January 2023, in the U.S., the number of new cancer cases is predicted to be 1,958,310, and it is predicted that cancer will cause 609,820 deaths across the U.S. in the same year.                                          


Request a Free sample to learn more about this report.


In the U.S., cancer is the leading cause of death, with lung cancer accounting for around 7% of cancer related deaths in the country.


RESTRAINING FACTORS


Availability of Alternative Tests to Limit Product Adoption 


One of the important factors impeding the U.S. c-reactive protein testing market growth is the availability of alternative tests specific to particular disease conditions. As this test is not a self-sufficient diagnostic test for any particular disease, healthcare professionals do not rely on the results of this test for disease management.


As this test is a non-specific marker of inflammation, there is a requirement for a specific test for the accurate diagnosis of any disease. Thus, the availability of such alternative disease diagnostic methods slowdowns the market’s growth to a certain extent.


SEGMENTATION


By Product Analysis


Based on product type, the market is segmented into reagents & kits and instruments.


The reagents & kits segment held the dominating position in the market in 2022. Key factors supporting the segment’s dominance include low prices and the repeated purchases of these products with the increasing number of tests being performed in the country.


On the other hand, the instruments segment is expected to witness comparatively slower growth during the forecast period. The growth of this segment is driven by an increasing number of regulatory approvals resulting in increased availability of products in the market.


By Assay Type Analysis


Based on assay type, the market is classified into Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), immunoturbidimetric assay, and others.


In 2022, the immunoturbidimetric assay segment dominated the U.S. market. The majority of the currently available products are based on this technology, in turn dominating this market.


On the other hand, the enzyme-linked immunosorbent assay (ELISA) segment is anticipated to exhibit considerable growth over the forecast period. Several advantages offered by ELISA assays support the increasing use of these assays in the market. These advantages include low cost, high specificity, ease of preparation, low detection limit, ease of operation, and others.


By Detection Range Analysis


Based on detection range, the market is categorized into conventional CRP and Hs-CRP.


The conventional segment accounted for the highest market share in 2022. The growth can be attributed to the high prevalence of autoimmune diseases and other inflammatory conditions in the U.S. population.


On the other hand, as the Hs-CRP test is commonly used to predict the risk of heart disease, the increasing number of individuals suffering from cardiovascular diseases increases the demand for this test, driving the segment’s growth.


By Setting Analysis


Based on product type, the market is segregated into laboratory testing, and point of care (POC) testing.


The laboratory segment accounted for the largest U.S. c-reactive protein testing market share in 2022. Key factors supporting the segment’s dominance include the easy availability of these tests in laboratory settings and the increasing patient pool opting for this testing in laboratories.


On the other hand, the Point Of Care (POC) segment is anticipated to grow at the fastest growth rate over the forecast period. This can be attributed to the increasing product launches and advancements in technologies for C-reactive protein testing.


By End User Analysis


Based on end user, the market is divided into hospitals & clinics, diagnostic laboratories, and others.


In 2022, the diagnostic laboratories segment captured the dominating share of the market. This can be attributed to healthcare professionals’ increasing prescription of this test. Professionals use this test to diagnose and monitor inflammatory conditions, including trauma, sepsis, and malignancies.


The hospitals & clinics segment is estimated to grow significantly over the forecast period. High prevalence of chronic diseases results in increased hospitalization and longer hospital stays that positively impact the segment’s growth.


KEY INDUSTRY PLAYERS


The competitive landscape for the U.S. c-reactive protein testing market is highly fragmented, with the presence of both established and emerging players. An organization's influence doesn’t singularly determine the market's growth trajectory. Key players in this market include Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, and Quest Diagnostics Incorporated. These companies are focusing on expanding their product portfolio through various strategic initiatives. Other prominent entities operating in the market include Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Abaxis, and Creative Diagnostics.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS: 



  • December 2022 – The U.S. FDA granted 510(k) clearance for Siemens Healthcare Diagnostics Products GmbH’s CardioPhase hsCRP prognostic test.

  • April 2022: The U.S. FDA approved ProciseDx’s ProciseDx instrument and C reactive protein test.


REPORT COVERAGE


An Infographic Representation of U.S. C-Reactive Protein Testing Market

To get information on various segments, share your queries with us



The market report provides a detailed analysis of the market. It focuses on key market segments such as product, assay type, detection range, setting, and end user. Additionally, it includes detailed insights on market dynamics, new product launches, key industry developments such as mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. Additionally, the report consists of several factors that have contributed to the market’s growth. The report also provides the competitive landscape of the U.S. market.


Report Scope & Segmentation






















































ATTRIBUTE



DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year 



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 5.1% from 2023 to 2030



Unit



Value (USD Million)



Segmentation



By Product



  • Reagents & Kits

  • Instruments



By Assay Type



  • Chemiluminescence Immunoassay (CLIA)

  • Enzyme-Linked Immunosorbent Assay (ELISA)

  • Immunoturbidimetric Assay

  • Others



By Detection Range



  • Conventional CRP

  • Hs-CRP



By Setting



  • Laboratory Testing

  • Point-of-Care (POC) Testing



By End User



  • Hospitals & Clinics

  • Diagnostic Laboratories

  • Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 691.6 million in 2022.

The market is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).

By setting, the laboratory testing segment accounted for a significant share of the market.

Abbott, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd. are some of the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 90

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X